Andrew Davis

Jan 8, 2025 | jamanetwork.com | Peggy B Leung |Andrew Davis |Joshua Davis

JAMA Clinical Guidelines Synopsis Corticosteroids for Sepsis, Acute Respiratory Distress Syndrome, or Community-Acquired Pneumonia Many acutely ill patients, including those hospitalized with severe pulmonary infections, have a dysregulated systemic inflammatory response, characterized by hypothalamic-pituitary-adrenal axis dysfunction, altered cortisol metabolism, and tissue corticosteroid resistance.1 Given the growing body of evidence regarding corticosteroid use in critical illness, this...

Jul 18, 2024 | onclive.com | Andrew Davis

Andrew Davis, MD, assistant professor, medicine, Division of Medical Oncology, Washington University School of Medicine, medical oncologist, Siteman Cancer Center, discusses the use of antibody-drug conjugates (ADCs) in patients with breast cancer, highlighting recent updates with these agents in the treatment paradigm.

Jul 10, 2024 | onclive.com | Andrew Davis

Andrew Davis, MD, assistant professor of medicine, Division of Medical Oncology, Washington University School of Medicine, medical oncologist, Siteman Cancer Center, discusses an ongoing phase 1 trial (NCT05372614) investigating the combination of neratinib and fam-trastuzumab deruxtecan-nxki (Enhertu) in patients with metastatic HER2-positive solid tumors.

Jul 2, 2024 | onclive.com | Andrew Davis

CommentaryVideoJuly 2, 2024Author(s):Andrew Davis, MD, discusses how antibody-drug conjugates could continue to reshape the breast cancer treatment paradigm. Andrew Davis, MD, assistant professor of medicine, Division of Medical Oncology, Washington University School of Medicine, medical oncologist, Siteman Cancer Center, discusses how the continued development of antibody-drug conjugates (ADCs) could reshape the breast cancer treatment paradigm.

Nov 1, 2023 | tabletalkmagazine.com | Jonathan Master |Andrew Davis

You have {{ remainingArticles }} free {{ counterWords }} remaining.You've accessed all your free articles. Unlock the Archives for Free Request your free, three-month trial to Tabletalk magazine. You’ll receive the print issue monthly and gain immediate digital access to decades of archives. This trial is risk-free. No credit card required. Try Tabletalk NowAlready receive Tabletalk magazine every month? Verify your email address to gain unlimited access. {{ error }}Need help?